Recent

% | $
Quotes you view appear here for quick access.

ACADIA Pharmaceuticals Inc. Message Board

  • drmiller355 drmiller355 Nov 27, 2012 12:16 PM Flag

    BASHERS WANT YOUR SHARES CHEAP. NEEDHAM GIVES $9 TARGET. LINK

    The Street insider 11/27
    Needham & Company Upgrades Acadia Pharmaceuticals (ACAD) to Buy
    Article Related Press Releases (2) Related Articles (3) Stock Quotes (1) Comments (0
    Intra-day Needham & Company upgraded Acadia Pharmaceuticals (NASDAQ: ACAD) from Hold to Buy with a price target of $9, following successful top-line results from its pivotal Phase III trial evaluating the efficacy, tolerability and safety of pimavanserin in patients with Parkinson’s disease psychosis.

 
ACAD
48.60-0.70(-1.42%)Jul 29 4:00 PMEDT